Search Log In

fig14

From:  Study of biological markers in skin quality treatment by subcutaneous injection of a stabilized composition of 26 mg/mL of high molecular weight HA
Study of biological markers in skin quality treatment by subcutaneous injection of a stabilized composition of 26 mg/mL of high molecular weight HA

Figure 14. Fibrillin-1 immunostaining (percentage of interest area covered by the immunostaining) in the dermal layer on Day 8 (D8) after injection. **P < 0.01 (99%) vs. control.

Plastic and Aesthetic Research
ISSN 2349-6150 (Online)   2347-9264 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties